Sophie Barillé‐Nion

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

Nicola Giuliani, Régis Bataille, Cristina Mancini et al. · Blood · 2001 · 413 citations · Full text

Medicine, Cell Biology, Oncology +15

Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

Nicola Giuliani, Simona Colla, Roberto Sala et al. · Blood · 2002 · 266 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.

Régis Bataille, Gaëtan Jégo, Nelly Robillard et al. · PubMed · 2006 · 225 citations

Medicine, Hematology, Oncology +13

Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment

Sophie Derenne, Martine Amiot, Sophie Barillé‐Nion et al. · Journal of Bone and Mineral Research · 1999 · 197 citations · Full text

Medicine, Oncology, Pharmacology +14

Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells

Sophie Barillé‐Nion, Camélia Akhoundi, M. Collette et al. · Blood · 1997 · 182 citations · Full text

Medicine, Cell Biology, Oncology +13